ELIXF (Elixxer) Beta: 20.4931 (As of Jun. 26, 2026)


What is Elixxer Beta?

Elixxer ELIXF Beta is 20.4931 as of Jun. 26, 2026. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Elixxer's Beta is 20.4931.

Elixxer  (OTCPK:ELIXF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Elixxer Beta Related Terms

Elixxer Beta Historical Data

* Premium members only.

The historical data trend for Elixxer's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer Beta Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.05 4.37 4.73 5.30 27.13

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.30 5.45 4.97 15.72 27.13

ELIXF vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixxer Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Beta distribution charts can be found below:

* The bar in red indicates where Elixxer's Beta falls into.


Elixxer Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 20.4931 mean?
Elixxer (ELIXF) has a Beta of 20.4931 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Elixxer and its competitors.
Is Elixxer's Beta too high?
Elixxer's current Beta is 20.4931.
How does Elixxer's Beta compare to ZTS?
Elixxer's Beta of 20.4931 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Elixxer and its competitors. Elixxer's current Beta is 20.4931. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixxer stock overvalued right now?
Elixxer (ELIXF) has a current Beta of 20.4931. The current Beta is 20.4931. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Elixxer (ELIXF), the current Beta is 20.4931 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.